Dimensional Fund Advisors’s Heron Therapeutics HRTX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-318,705
| Closed | -$1.82M | – | 3496 |
|
2022
Q1 | $1.82M | Sell |
318,705
-18,176
| -5% | -$104K | ﹤0.01% | 2854 |
|
2021
Q4 | $3.08M | Buy |
336,881
+19,682
| +6% | +$180K | ﹤0.01% | 2725 |
|
2021
Q3 | $3.39M | Sell |
317,199
-311,146
| -50% | -$3.33M | ﹤0.01% | 2687 |
|
2021
Q2 | $9.75M | Buy |
628,345
+15,161
| +2% | +$235K | ﹤0.01% | 2368 |
|
2021
Q1 | $9.94M | Buy |
613,184
+87,292
| +17% | +$1.41M | ﹤0.01% | 2327 |
|
2020
Q4 | $11.1M | Sell |
525,892
-12,017
| -2% | -$254K | ﹤0.01% | 2236 |
|
2020
Q3 | $7.97M | Buy |
537,909
+107,283
| +25% | +$1.59M | ﹤0.01% | 2298 |
|
2020
Q2 | $6.33M | Buy |
430,626
+170,391
| +65% | +$2.51M | ﹤0.01% | 2388 |
|
2020
Q1 | $3.06M | Buy |
260,235
+35,247
| +16% | +$414K | ﹤0.01% | 2578 |
|
2019
Q4 | $5.29M | Hold |
224,988
| – | – | ﹤0.01% | 2590 |
|
2019
Q3 | $4.16M | Buy |
224,988
+110,892
| +97% | +$2.05M | ﹤0.01% | 2656 |
|
2019
Q2 | $2.12M | Buy |
+114,096
| New | +$2.12M | ﹤0.01% | 2886 |
|
2019
Q1 | – | Sell |
-17,338
| Closed | -$450K | – | 3453 |
|
2018
Q4 | $450K | Buy |
+17,338
| New | +$450K | ﹤0.01% | 3162 |
|
2015
Q1 | – | Sell |
-580
| Closed | -$6K | – | 3362 |
|
2014
Q4 | $6K | Hold |
580
| – | – | ﹤0.01% | 3472 |
|
2014
Q3 | $5K | Hold |
580
| – | – | ﹤0.01% | 3508 |
|
2014
Q2 | $7K | Hold |
580
| – | – | ﹤0.01% | 3551 |
|
2014
Q1 | $8K | Buy |
+580
| New | +$8K | ﹤0.01% | 3554 |
|